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A B S T R A C T   
Pistacia lentiscus L. is a sclerophyllous shrub capable of growing under harsh climatic conditions especially in the 
Mediterranean Basin. Different products can be obtained from this plant, such as essential oil, mastic gum or even 
fixed oil. The last is well known for its flavor which is mainly exploited in the food industry. Additionally, it has 
been traditionally used in the treatment of skin diseases, but, at the moment, any suitable formulation for skin 
delivery has been formulated and its biological effects was not deeply confirmed. Given that, in the present study, 
the lentisk oil has been formulated in liposomes at different concentrations (10, 20, 30 mg/ml) and their 
physicochemical, technological and main biological properties have been evaluated. Vesicles were prepared by 
using natural soy lecithin and a green and organic solvent free method, thus obtaining spherical, small (~ 
118 nm), homogeneously dispersed (0.27) and highly negatively charged (~ − 62 mV) vesicles. The used amount 
of oil loaded in liposomes (10, 20, 30 mg/ml) modulated the penetration ability of vesicles in the skin, favoring 
the deposition of the payload in the deeper strata. The loading in the vesicles potentiated the ability of oil to 
counteract the damaging effects caused by hydrogen peroxide in keratinocytes and fibroblasts and facilitate their 
migration in a cell monolayer lesion. Overall findings suggested that the incorporation of lentisk oil in liposomes 
made from soy lecithin can be an alternative and natural approach to exploit it in pharmaceutical ad cosmetical 
applications and manufacturing natural products suitable for the treatment of skin lesions.   
1. Introduction 
Pistacia lentiscus L. commonly known as lentisk or mastic tree in 
Greece, is a sclerophyllous Mediterranean shrub belonging to the Ana-
cardiaceae family [1]. The fruits, galls, resin and leaves of P. lentiscus 
have been traditionally used in folk medicine to treat a wide range of 
diseases in the whole Mediterranean Basin, where it grows wild with a 
large geographical and bio-climatical distribution range [2]. The main 
traditional products obtained from this plant are the edible oil from the 
berries and the mastic gum, a resin secreted by incising the tree bark [3]. 
The fixed oil has been used mainly as food dressing, flavouring, colorant 
and antioxidant agent, especially in Tunisia and Greece, but also as 
ethnomedical remedy for the treatment of gastrointestinal upsets, 
gastric ulcers or skin illness. In Sardinia, this oil was mainly used as 
flavour in cuisine, but also as ointment to treat wounds and as foot 
deodorant [4]. In the Middle East, lentisk oil was particularly appreci-
ated for its antiseptic properties, and was used to treat wounds and 
gastric ulcers. Since ancient times, many beneficial properties have been 
ascribed to this oil, Greeks and Latins used mastic oil as diuretic, 
anti-inflammatory, antiseptic and healing agent to treat gastric ulcers, 
local skin diseases and coughs and colds [5,6]. These traditional uses 
and its nutritional properties have been confirmed by both in vitro and 
* Corresponding author. 
E-mail address: manconi@unica.it (M. Manconi).  
Contents lists available at ScienceDirect 
Biomedicine & Pharmacotherapy 
journal homepage: www.elsevier.com/locate/biopha 
https://doi.org/10.1016/j.biopha.2021.112351 
Received 30 August 2021; Received in revised form 17 October 2021; Accepted 19 October 2021   
Biomedicine & Pharmacotherapy 144 (2021) 112351
2
in vivo studies [7–9]. In addition, the chemical composition of the len-
tisk fixed oil has been investigated disclosing a high content of bio-
actives such as fatty acids, especially oleic, palmitic and linoleic, and 
phenolic compounds, such as tocopherols, carotenoids and anthocya-
nins [10,11]. The unsaponifiable fraction of the fixed oil is responsible of 
its beneficial effect in the healing of the injured skin [3]. The antioxidant 
compounds promote the repair of skin damages and inhibit lipid 
oxidation and depletion of antioxidant defence enzymes [12]. 
A modern strategy, to improve the efficacy at skin level of such lipid 
phytocomplexes, is their incorporation into nanocarriers. However, the 
P. lentiscus fixed oil was never loaded into nanocarriers while the 
essential oil obtained from this plant was encapsulated in polymeric 
nanoparticles specifically designed for skin application [13]. 
For the first time in this study, the P. lentiscus fixed oil has been 
loaded in liposomes, which have been previously used to load several 
essential oils but only few fixed oils whose incorporation allowed to 
improve their beneficial activities (e.g. Nigella sativa seed oil and neem 
oil) [14,15]. Liposomes were made with natural occurring soy lecithin 
and the lentisk oil was loaded at increasing concentrations (10, 20, 
30 mg/ml). The main physicochemical (mean diameter, polydispersity 
index, zeta potential) and technological (entrapment efficiency, storage 
stability and skin penetration ability) properties of vesicles were eval-
uated and a preliminary evaluation of their biological abilities, such as 
biocompatibility, protection against oxidative damages and in vitro 
promotion of migration of keratinocytes and fibroblasts in a cell 
monolayer lesion, has been carried out as well. 
2. Materials and methods 
2.1. Materials 
Soy lecithin was purchased from Galeno (Potenza, Italy). The 
P. lentiscus oil was a kind gift of a local enterprise, SSA Mediflora (Pula, 
CA, Italy). All the chemical products and solvents of analytical grade 
were purchased from Sigma-Aldrich (Milan, Italy). Cell medium, foetal 
bovine serum, penicillin, streptomycin and all the other reagents and 
plastic for cell culture were purchased from Life Technologies Europe 
(Monza, Italy). 
2.2. Sample preparation 
Soy lecithin (60 mg/ml) and lentisk oil (10 or 20 or 30 mg/ml) were 
weighed in a glass vial and left hydrating overnight with water (2 ml) to 
promote the swelling of the phospholipid. The obtained dispersions 
were sonicated (5 s on and 2 s off, 20 cycles; 13 μ of probe amplitude) 
with a high intensity ultrasonic disintegrator (Soniprep 150, MSE 
Crowley, London, United Kingdom), to obtain 10lentisk-, 20lentisk- and 
30lentisk-liposomes (Table 1). 
The free bioactives contained in the oil and not entrapped inside the 
vesicle bilayer were separated dialysing the samples (1 ml) against water 
(2.5 litres). Dialysis tubing (Spectra/Por® membranes, 12–14 kDa MW 
cut-off, 3 nm pore size; Spectrum Laboratories Inc., DG Breda, The 
Netherlands) were filled with the vesicle dispersions and transferred in a 
bath of distilled water (2,5 litres) maintained under stirring and at room 
temperature for 4 h. The water was replaced every hour. The used water 
(10 litres total) was able to theoretically remove all the bioactives con-
tained in 1 ml of liposome dispersions. 
2.3. Vesicle characterization 
Cryogenic electron transmission microscopy (cryo-TEM) analyses 
were performed by using a Tecnai F20 TEM (FEI Company). Briefly, a 
thin aqueous film was formed on a glow-discharged holey carbon grid 
and vitrified by plunging into ethane, using a Vitrobot (FEI Company, 
Eindhoven, The Netherlands), which was then observed in a low dose 
mode, at 200 kV and at a temperature around ~− 172 ◦C [16]. 
The average diameter, polydispersity index and zeta potential were 
determined by means of Photon Correlation Spectroscopy method by 
using a Zetasizer Ultra (Malvern Panalytical Ltd, Worcestershire, UK). 
Before the analysis, samples were diluted (1:100) with water to be 
optically clear and avoid the attenuation of the laser beam by the par-
ticles along with the reduction of the scattered light that can be detected 
[19]. 
Entrapment efficiency was calculated as the percentage of the 
amount of bioactives initially used versus that found in dialyzed sam-
ples. The quantification of lentisk oil was performed measuring fatty 
acid methyl ester (FAME) by gas chromatography coupled to flame 
ionization detector after derivatization with sodium methoxide. 
2.4. Stability studies 
The vesicle stability was assessed by monitoring the vesicle average 
size and zeta potential over 90 days of storage at room temperature 
(25 ± 1 ◦C). 
2.5. In vitro skin delivery studies 
Experiments were performed under non-occlusive conditions by 
using Franz cells (diffusion area 0.785 cm2) and new-born pig skin. One- 
day-old pigs were provided by a local slaughterhouse. The skin, stored at 
− 80 ◦C, was cut in specimens (n = 6 for each formulation), which were 
pre-hydrated in saline at 25 ◦C for 12 h. When properly hydrated, they 
were sandwiched between donor and receptor compartments of the 
Franz diffusion cells. The receptor was filled with 5.5 ml of saline, 
continuously stirred and thermostated at 37 ± 1 ◦C. Vesicles were 
labelled with 1,2-dioleolyl-sn-glycero-3-phosphoethanolamine-N-(liss-
amine rhodamine B sulfonyl, 0.035 mg/ml; phospho-rhodamine) and 
applied (100 μl) on the skin surface. After 4 and 8 h of treatment, the 
skin specimens were gently washed with distilled water, the diffusion 
area punched out and rapidly frozen at − 80 ◦C. Sections of skin (7 µm 
thickness) were cut with a cryostat (Leica CM1950, Barcelona, Spain) 
orthogonally (in the z axis) to the surface and examined under a Fluo-
View FV1000 inverted confocal microscope (Olympus, Barcelona, 
Spain) equipped with an Ultraviolet-Visible light laser. Images with a 
field size of 1024 × 1024 µm were generated by using an UPlanSApo 
20 × objective NA 0.75. Phospho-rhodamine was excited at 559 nm and 
detected at 578 nm. 
2.6. Biocompatibility and protection provided by liposomes against cell 
oxidative stress 
Human keratinocytes (HaCaT) and primary mouse embryonic fi-
broblasts (3T3) (ATCC collection, Manassas, VA, USA) were grown as 
monolayer in 75 cm2 flasks, incubated in 100% humidity and 5% CO2 at 
37 ◦C, by using DMEM with high glucose (4500 mg/l glucose), supple-
mented with foetal bovine serum (10%), penicillin and streptomycin 
(1%), as culture medium. 
The biocompatibility of samples was evaluated seeding keratinocytes 
and fibroblasts (7,5 ×103 cells/well) into 96-well plates and incubating 
them for 24 h. The lentisk oil in dispersion or loaded into liposomes at 
different dilutions (1:500, 1:1.000, 1:10.000, 1:100.000, corresponding 
Table 1 
Amount of each component used to prepare empty and lentisk oil loaded 
liposomes.   
Lentisk oil Soy lecithin Water  
(mg/ml) (mg/ml) (ml) 
Empty liposomes –  60  1 
10lentisk-liposomes 10  60  1 
20lentisk -liposomes 20  60  1 
30lentisk -liposomes 30  60  1  
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to 60, 30, 3, 0.3 μg/ml of oil using 30lentisk-liposomes and dispersion; 
40, 20, 2, 0.2 μg/ml of oil using 20lentisk-liposomes and 20, 10, 1, 
0.1 μg/ml of oil using 10lentisk-liposomes) was added. Cells were 
incubated for 48 h and after their viability was measured using the MTT 
[3(4,5-dimethylthiazolyl-2)− 2, 5-diphenyltetrazolium bromide] color-
imetric assay. Cells were washed 3 times with fresh medium and 100 μl 
of MTT reagent (0.5 mg/ml in PBS) was added in each well. After 2–3 h, 
the formed formazan crystals were dissolved in dimethyl sulfoxide and 
their concentration was spectrophotometrically quantified at 570 nm 
with a microplate reader (Synergy 4, Reader BioTek Instruments, AHSI 
S.P.A, Bernareggio, Italy). 
The ability of formulations to avoid damages caused by oxidative 
stress was evaluated stressing keratinocytes and fibroblasts (7,5 ×103 
cells/well) with hydrogen peroxide (30% diluted 1:30.000 v/v with PBS) 
for 4 h and simultaneously treating them with the lentisk oil in disper-
sion or loaded in liposomes, diluted (1:10000) with medium to reach 
3 μg/ml of oil using 30lentisk-liposomes and dispersion, 2 μg/ml of oil 
using 20lentisk-liposomes and 1 μg/ml of oil using 10lentisk-liposomes. 
At the end of each experiment, the survival of cells was measured by 
using the MTT test. Viability was calculated as percent of viability of 
cells incubated with samples versus the viability of untreated control 
cells (100% viability). 
2.7. In vitro scratch assay 
The ability of the lentisk oil in dispersion or loaded into liposomes to 
stimulate both cell proliferation and migration was evaluated by 
measuring the speed rate of the wound healing as a function of the time 
of exposition to the samples (scratch assay). Cells were cultured in 6- 
well plates until the complete confluence was reached. Then, a linear 
scratch was generated by using a sterile plastic pipette tip. The scattered 
fragments of cells were removed by gently washing with fresh medium. 
The cells were treated with lentisk oil in dispersion or loaded in lipo-
somes properly diluted (1:10000) with medium (3 μg/ml of oil using 
30lentisk-liposomes and dispersion, 2 μg/ml of oil using 20lentisk-lipo-
somes and 1 μg/ml of oil using 10lentisk-liposomes) and incubated for 
48 h. Untreated cells and cells treated with the aqueous dispersion of the 
essential oil were used as controls. The changes of the area of the lesion 
were monitored by using an optical microscope (10 × objective) and the 
related images were captured at initial time zero to measure the 
wounded area immediately after scratching (a0) and at 24, and 48 h (aΔ) 
to measure the areas during the treatment. The captured images were 
quantified by Java’s image J software (http://rsb.info.nih.gov) by 
measuring the area of the wound [18]. The migration of cells toward the 
wounds was expressed as percentage of wound closure: WC% = [(a0 – 
a∆/ a0] × 100%. 
2.8. Statistical analysis of data 
Results are expressed as the mean ± standard deviation. Analysis of 
variance (ANOVA) was used for multiple comparisons of means, and the 
Tukey’s test and Student’s t-test were performed to substantiate differ-
ences between groups using XL Statistics for Windows. The differences 
were considered statistically significant for p < 0.05. 
3. Results 
3.1. Vesicle characterization 
The lentisk oil was loaded in liposomes and the maximum amount to 
be loaded was found by a pre-formulation study, in which increasing 
amount of oil, from 10 mg/ml to 50 mg/ml, were used. 40 and 50 mg/ml 
of lentisk oil led the formation of large vesicles, highly polydispersed 
and instable, while those loading 10, 20 and 30 mg/ml of oil were small 
in size, homogeneously dispersed and highly negatively charged. Given 
that, 10, 20 and 30 mg/ml of lentisk oil were selected as suitable 
concentrations to be incorporated in liposomes. Cryo-TEM images dis-
closed the formation of small vesicles, homogeneously dispersed and 
with a spherical and uniform shape (Fig. 1). 
Photon correlation spectroscopy analyses confirmed the findings of 
cryo-TEM analyses, as the formation of small and homogeneous systems 
was detected (Table 2). 
Empty liposomes, without lentisk oil, were small (~122 nm), slightly 
polydispersed (0.26) and negatively charged (~− 60 mV). The loading 
of 10 mg/ml of lentisk oil allowed a significant decrease of the mean 
diameter, which was ~104 nm, thus significantly smaller than that of 
the other formulations (p < 0.05, versus the values of other vesicles), 
while the polydispersity index and the surface charge remained almost 
unchanged. Differently, the loading of 20 and 30 mg/ml of the oil led the 
formation of slightly bigger vesicles, with diameter similar to that of the 
empty ones (~121 nm, p > 0.05 among the mean diameter of empty, 
20lentisk- and 30lentisk-liposomes). Even the homogeneity of the vesi-
cles was affected by the amount of lentisk oil incorporated, but with a 
reverse trend as the lower value of polydispersity index has been found 
for 30lentisk-liposomes. The zeta potential remained strongly negative, 
irrespective of the used amount of oil and was mainly due to the negative 
group of phospholipids at the pH of dispersions, ~5.5 [19]. All tested 
liposomes incorporated high amount of lentisk oil, which increased as 
the amount of lentisk oil used for their preparation also increased. 
The mean diameter of empty liposomes stored at room temperature 
for 90 days, slightly increased up to ~200 nm and the zeta potential 
became more negative (Fig. 2). The mean diameter of 10lentisk- and 
20lentisk-liposomes increased only at 90 days up to ~150 nm while any 
important variation was detected for the other parameters. Liposomes 
loading the higher amount of lentisk oil, remained almost constant, 
disclosing a better stability on storage of these vesicles (Fig. 2). 
3.2. In vitro skin delivery 
The ability of liposomes to promote the delivery of lentisk oil to the 
skin was evaluated in vitro by using new-born pig skin and vesicles 
labelled with a phospholipid linked to the fluorescent rhodamine 
(phospho-rhodamine), which allowed the visualization of the vesicle 
distribution in the different strata of the skin (Fig. 3). 
The vesicles pathway was strongly affected by the amount of lentisk 
oil incorporated. Indeed, empty vesicles were confined on the skin sur-
face, and any significant passage of vesicles up to the deeper skin layers 
has been detected. Similarly, using the lower amount of oil the fluo-
rescence provided by vesicles was mainly confined on the skin surface 
and a lower fluorescence was detectable in the deeper strata, irre-
spective of the duration of the treatment (4 or 8 h). The use of higher 
amount of oil (20 and 30 mg/ml) led to a dipper distribution of the 
vesicles, especially after 8 h of treatment. At 4 h, the red fluorescence 
was mainly evident on the skin surface (especially for 30lentisk-lipo-
somes) and in the deeper strata was less intense. At 8 h of treatment 
the fluorescence was mainly evident and well distributed in the deeper 
strata, especially in the dermis confirming a strong penetration of lipid 
components. Probably the free lentisk oil could act as penetration 
enhancer by promoting the fluidification of lipid lamellar matrix 
imbibing the corneocytes and favouring the passage of the intact 
vesicles. 
3.3. Biocompatibility and protection provided by liposomes against 
oxidative stress in both keratinocytes and fibroblasts 
The most representative cells of the skin, keratinocytes and fibro-
blasts, were used to evaluate the cytotoxicity of samples (Fig. 4). Using 
the lentisk oil dispersion at the lower dilutions, (corresponding to 
60–30 μg/ml of oil) the cell viability was lower (~77%, p < 0.05 versus 
the viability obtained incubating the cells with all other samples and 
dilutions), while at the lower concentrations (3 and 0,3 μg/ml) was 
~93%. The same viability value (p > 0.05) was obtained loading the oil 
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in liposomes at lower dilutions and higher concentrations (60–30 or 
40–20 or 20–10 μg/ml of oil). Using the three lentisk oil formulations at 
lower concentrations (3–0.3 or 2–0.2 or 1–0,1 μg/ml of oil) the cell 
viability was improved up to ~112% (p > 0.05 among the groups), 
disclosing a proliferative effect of lentisk-liposomes at these dilutions. 
The incubation of fibroblasts with lentisk oil, in dispersion or loaded in 
10lentisk-liposomes, increased the cell viability up to ~112%, irre-
spective to the used dilution (p > 0.05). The incubation with 20lentisk- 
and 30lentisk-liposomes at lower dilutions (60–40 or 40–20 μg/ml of 
oil) provided the same cell viability (~112%, p > 0.05 versus the 
Fig. 1. Representative Cryo-TEM images of 10lentisk-liposomes (A), 20lentisk-liposomes (B) and 30lentisk-liposomes (C).  
Table 2 
Mean diameter (MD), polydispersity index (PI), zeta potential (ZP) and entrapment efficiency of empty vesicles and 10lentisk-liposomes, 20lentisk-liposomes and 
30lentisk-liposomes. Samples were diluted with water (1:100) before the analysis. Mean values ± standard deviations are reported (n = 6). Symbol * indicates values 
statistically different from the others.   
Mean diameter (nm) Polydispersity index (PI) Zeta Potential (mV) Entrapment efficiency (%) 
Empty liposomes 121 ± 3 0.26 –60 ± 7 – 
10lentisk-liposomes *104 ± 8 0.27 –63 ± 5 72 ± 7 
20lentisk -liposomes 116 ± 15 0.25 –67 ± 5 82 ± 9 
30lentisk -liposomes 126 ± 13 0.23 –67 ± 3 85 ± 5  
Fig. 2. Mean diameter, polydispersity index and zeta potential of empty liposomes, 10lentisk-liposomes, 20lentisk-liposomes and 30lentisk-liposomes measured by 
Photon Correlation Spectroscopy, during 90 days of storage at 25 ◦C. The mean values ± standard deviations (error bars) are reported (n = 6). Each symbol (*, ◦, #, 
+), indicates a value statistically different from the others. 
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viability of samples incubated with the dispersion) while the lower 
concentrations (4–0.4 or 2–0.2 μg/ml of oil) provided the highest values 
of viability, ~123%, (p < 0.05 versus the viability of samples incubated 
with samples and dilutions). 
Considering that lentisk-liposomes were not toxic at the tested di-
lutions and the dilution 1/100,000, corresponding to concentrations 3, 2 
or 1 μg/ml of oil provided proliferation of keratinocites and fibroblasts, 
this dilution was selected to evaluate the bioactivity of formulations in 
further studies. 
The ability of formulations to counteract the toxic effect of hydrogen 
peroxide in cells were evaluated as well (Fig. 5). The treatment of cells 
with hydrogen peroxide led to a significant reduction of keratinocytes 
Fig. 3. Representative confocal laser scanning microscopy images of phospho-rhodamine (red) distribution in a skin section (z axis) after 4 and 8 h of treatment with 
empty liposomes, 10lentisk-liposomes, 20lentisk-liposomes and 30lentisk-liposomes. 
Fig. 4. Cell viability of human keratinocytes and fibroblasts treated for 48 h with lentisk oil in dispersion or loaded in vesicles diluted 500, 1000, 10,000 and 100,000 
folds. Data are reported as mean values ± standard deviations (n = 9) of cell viability expressed as the percentage of untreated cells (100% of viability). Each symbol 
(#, *, ◦) indicates the same value. 
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and fibroblasts viability, which reached ~58% (p < 0.05 versus other 
values). The treatment of stressed cells with lentisk oil in dispersion led 
to a significant increase of cell viability up to ~77% (p < 0.05 versus 
other values), while the loading in vesicles ensure a protection of both 
keratinocytes and fibroblasts irrespective of the used formulation, as the 
cell viability was ~106% (P < 0.05 versus the values provided by the oil 
dispersion). Results confirmed the capability of the tested nanovesicles 
of inhibiting the toxic effect provided by the treatment with hydrogen 
peroxide. 
3.4. In vitro scratch assay 
In vitro scratch assay was carried out on a cell monolayer of 
keratinocytes and fibroblasts to evaluate the capability of oil in disper-
sion or loaded in liposomes of promoting the wound closure by 
favouring the cell migration. As previously reported, the samples were 
diluted to reach the concentration, which provided higher cell prolif-
eration (3 μg/ml of oil using 30lentisk-liposomes and dispersion, 2 μg/ 
ml of oil using 20lentisk-liposomes and 1 μg/ml of oil using 10lentisk-li-
posomes). The thickness of lesions was measured at different time points 
to evaluate the ability of formulations to favour not only the cell pro-
liferation but also their migrations versus the scratched region free of 
cell (Figs. 6 and 7). At 24 h, the percent closure of untreated cells was 
~20% and reached ~40% at 48 h. When the cells were treated with oil 
in dispersion or loaded into 10lentisk-liposomes, the behaviour was 
slightly better: ~20% at 24 h and ~60% at 48 h. A significant reduction 
Fig. 5. Protective effect of lentisk oil in dispersion (3 μg/ml) or loaded in 10lentisk-liposomes (1 μg/ml), 20lentisk-liposomes (2 μg/ml) and 30lentisk-liposomes 
(3 μg/ml), against hydrogen peroxide-induced oxidative stress in keratinocytes and fibroblasts. Data are reported as mean values ± standard deviation of cell 
viability expressed as the percentage of untreated cells (100% viability). Each symbol (*, ◦,#) indicates the same value. 
Fig. 6. Percentage of closure of a wound performed in a monolayer of keratinocytes and fibroblasts untreated or treated with lentisk oil in dispersion (3 μg/ml) or 
loaded in 10lentisk-liposomes (1 μg/ml), 20lentisk-liposomes (2 μg/ml) and 30lentisk-liposomes (3 μg/ml), as a function of the time. Mean values ± standard de-
viations (error bars) are reported (n = 6). Symbol * indicates values statistically different from 20lentisk and 30lentisk-liposomes. 
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(p < 0.05) of the wound thickness was reached by using liposomes 
loading 20 and 30 mg/ml of lentisk oil (20- and 30lentisk-liposomes), 
being the closure ~80% at 24 h and almost complete (~100% 
closure), at 48 h, disclosing an optimal potential of these formulations in 
accelerating the healing of a wound performed in a cell monolayer. 
4. Discussion 
Pistacia lentiscus is a resilient plant capable of growing under hard 
climatic conditions characterized by nutrient and water scarcity and 
long-term exposure to extensive solar radiation and high temperatures 
[20]. To resist to these conditions, it produces several secondary me-
tabolites, which can positively affect their curative and beneficial effects 
[21]. Its fixed oil obtained from the berries is rich in unsaturated fatty 
acids (~70%), especially oleic acid, which is dominant, linoleic and 
palmitic acids, while only ~25% of saturated fatty acids are present 
[22]. Moreover, several phenolic compounds are contained in the oil 
and they are responsible for oil stability and antioxidant properties [23]. 
Thanks to this content, lentisk oil can protect the skin cells from 
oxidative injury inhibiting the lipid oxidation and subsequent malon-
dialdehyde formation, inducted by treatment with hydrogen peroxide 
[12]. The lipid peroxidation product (malondialdehyde) if accumulated 
in tissue, readily interacts with functional groups of proteins, lipopro-
teins, DNA, and RNA involving different pathological states [24]. It was 
disclosed that lentisk oil has a positive impact on skin reparation owing 
to its antioxidant properties and ability to promote cell proliferation, 
collagen synthesis and dermal reconstruction [25]. Additionally, it can 
repair the lipid barrier function of skin, similarly to other natural oils, 
since its moisturizing properties [25]. It was also proven that the fixed 
oil of lentisk promotes proliferation of fibroblasts and new synthesis of 
collagen [26]. Indeed, the collagen density in tissue of rats treated with 
this oil was significantly higher than that found with other treatments. 
The in vivo anti-inflammatory activity of oil was confirmed and related 
with its ability to inhibit or reduce the production of inflammatory 
mediators involved in the acute inflammatory response [27]. Lentisk oil 
seems to act as wound healing agent on one hand by the reduced pro-
duction of the inflammatory mediators, on the other hand thank to the 
antioxidant activity and stimulation of the production of antioxidant 
enzymes [27,28]. These previous studies confirmed the wound healing 
properties of lentisk oil, but its suitable formulation in highly-effective 
carries tailored for the skin delivery was not previously developed. In 
the light of this, this study was mainly aimed at loading the oil in stable 
and effective liposomes and evaluating the main benefits of its incor-
poration into them. Liposomes were prepared by using lecithin from soy 
(60 mg/ml), which is a natural occurring mixture of phospholipids, 
being phosphatidylcholine the main component associated with phos-
phatidylethanolamine, phosphatidylserine, and phosphatidylinositol 
and small amounts of other triglycerides, fatty acids, and carbohydrates 
[29]. Soy lecithin is usually separated from the crude vegetable oil 
source using non-toxic solvent and chromatographic procedures with 
low consumption of equipment, materials and energy, these positive 
factors are reflected in its low commercial price [22]. The use of lecithin 
to incorporate lentisk oil permitted to manufacture natural nano-
technological liposomes with a simple and easy scalable preparation 
method and only using natural plant-derived components [31]. The 
resulting vesicles were stable for 3 months of storage at room temper-
ature, especially when the highest amount of oil (30lentisk-liposomes) 
was used, probably because the oil intercalated in the bilayer giving a 
high fluidity and deformability of it. The amount of oil incorporated was 
also capable of positively affecting the penetration of vesicles in the 
deeper skin strata, indeed liposomes loading the higher amount of len-
tisk oil (30 mg/ml) accumulated especially in the dermis, which is the 
Fig. 7. Representative images of wound closure in a monolayer of keratinocytes and fibroblasts untreated or treated with lentisk oil in dispersion (3 μg/ml) or loaded 
in 10lentisk-liposomes (1 μg/ml), 20lentisk-liposomes (2 μg/ml) and 30lentisk-liposomes (3 μg/ml) at 0, 24 and 48 h. 
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stratum mainly involved in the regeneration of the skin during the 
wound healing process. In the present study, in addition to the formu-
lation suitability for skin application and its natural and scalable pro-
duction, the improvement of biological properties provided by the 
loading was also dilucidated. Actually, the lentisk oil in dispersion or 
loaded in liposomes was not toxic also if used at high concentrations. 
The oil dispersion slightly stimulated the proliferation of fibroblasts and 
not at all that of keratinocytes while its loading in liposomes at selected 
dilution (1/10,000) improved the proliferation of both keratinocytes 
and fibroblasts. Cell proliferation is not always associated to cell 
migration, being the latter a key parameter in the promotion of lesion 
closure. Given that, the ability of formulations to affect lesion closure 
was evaluated by the scratch assay. Results underlined that lentisk oil in 
dispersion provided only a low migration of keratinocytes and fibro-
blasts in the lesion zone, even if, in biocompatibility test, it favored 
proliferation of fibroblasts and not that of keratinocytes probably 
because the two effects are mediated by different biological mechanisms 
[32]. According to biocompatibility test, at the used dilution, the 
20lentisk and 30lentisk-liposomes improved the proliferation of kera-
tinocytes in a better extent than the oil dispersion and this positive effect 
was associated to a better cell migration in scratch assay. The improved 
rate of closure provided by lentisk-liposomes in fibroblast lesions can be 
also related to a collective migration driven by improved collagen pro-
duction [33]. Indeed, 3T3 fibroblasts can synthetize collagen [34]. 
Finally, lentisk oil in dispersion partially counteracted the toxic effect of 
hydrogen peroxide in cells while its loading in vesicles ensured a better 
protection guarantying the restoring of the healthy condition probably 
because the vesicles facilitate the internalization of the polyphenols 
contained in the oil, which, inside the cells are capable of scavenging the 
free radicals in a better extent than the dispersion [25]. Then, 
lentisk-liposomes can positively affect the local treatment of skin le-
sions, due to a synergic effect on reduction of oxidative stress, promotion 
of proliferation and migration of keratinocytes and fibroblasts and 
restoring effect of skin lipid barrier functions mostly expressed as 
emollient action [25,35]. This effect is improved by the incorporation of 
oil in liposomes, because the phospholipids, as the main components of 
cell membranes, are potent regulators of epithelial barrier function [36]. 
Overall findings suggested the high potential of lentisk oil loaded lipo-
somes in the treatment of skin lesions mainly associated to oxidative 
stress. 
5. Conclusions 
The fixed oil obtained from the berries of P. lentiscus has been 
incorporated into totally green and natural liposomes only composed of 
lecithin from soy. The combination of these two plant-derived products 
led the formation of a natural nanotechnological formulation, ideal for 
the treatment of skin wounds. Overall results suggested that the loading 
of lentisk oil into liposomes (especially 30 mg/ml) is a promising 
strategy to prepare natural and biocompatible nanoformulations, being 
both lentisk oil and soy phosphatidylcholine obtained from plants, 
which naturally assemble to form nanovesicles. In addition, this com-
bination of natural occurring components guaranties the stability of the 
system in dispersion and promote the accumulation of the bioactives in 
the skin especially in the dermis, and their ability to counteract damages 
induces by oxidative processes, thus promoting their beneficial effect on 
lesion regeneration and healing. 
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